NTBC Therapy: A Lifeline for Tyrosinemia Patients - NOTA Cares

Nitisinone, commonly known as NTBC, is a pivotal medication in managing hereditary tyrosinemia type 1 (HT-1). By inhibiting the breakdown of tyrosine, NTBC prevents the accumulation of toxic substances that can lead to severe liver and kidney complications. When combined with a carefully monitored low-tyrosine and low-phenylalanine diet, NTBC therapy significantly enhances the quality of life and prognosis for those affected by HT-1. Early diagnosis and consistent treatment are essential for optimal outcomes.
https://notacares.org/